We have mainly grown organically, but have bolstered our growth through a number of strategic acquisitions which have broadened our service portfolio and have added scale to existing services.
ICON acquires HumanFirst, a cloud-based technology company for life sciences supporting precision measurement in patient centered clinical research.
ICON acquires Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services.
ICON acquires PRA Health Sciences, creating the most advanced healthcare intelligence and clinical research organisation in the world
ICON acquires MedPass International, a leading European medical device CRO, regulatory and reimbursement consultancy
ICON acquires Symphony Clinical Research, a leading provider of at-home patient services and site support services
ICON acquires MediNova, an integrated network of clinical research sites across EMEA
ICON acquires MolecularMD to enhance laboratory offering in molecular diagnostic testing and immunohistochemistry
ICON acquires MAPI Group to become world’s 2nd largest provider of late phase services
ICON acquires Clinical Research Management Inc. to extend presence in the government sponsored research market
ICON selected by Genomics England to support the world's largest genome sequencing project
ICON selected by ICHOM to develop world’s first global healthcare outcomes benchmarking programme
ICON celebrates 25 years
ICON creates new global innovation hub in Ireland to advance clinical development
ICON acquires MediMedia Pharma Solutions to enhance market access and scientific communications capabilities
ICON acquires PMG Research Inc, an integrated network of clinical research sites in the US
ICON launches Medical Device and Diagnostics Research Group
ICON acquires Aptiv Solutions, a market leader in adaptive trial design and execution
ICON acquires staffing and FSP providers, ClinForce and Assent
ICON acquires Akos, an EU Provider of Pharmacovigilance and Drug Safety Services
ICON acquires PriceSpective, a global value strategy consultancy
ICON acquires Chinese CRO, BeijingWits
ICON acquires Oxford Outcomes, an international health outcomes consultancy
ICON acquires Firecrest Clinical, a technology provider specialising in site performance and study management
ICON acquires Timaq Medical Imaging Inc.
ICON acquires Veeda Laboratories, a UK Biomarker Lab
ICON acquires US Phase I Provider Healthcare Discoveries
ICON acquires US Bioanalytical Lab, Prevalere Life Sciences
ICON acquires European staffing group, DOCS International
ICON acquires Outcomes Research and Health Economics specialist, Ovation Research Group
ICON opens first Indian office in Chennai
ICON acquires medical imaging specialist, Beacon Bioscience Inc.
ICON acquires Medeval, a UK-based Phase I facility
ICON acquires US consulting firm, Globomax
ICON acquires staffing group, Managed Clinical Solutions
ICON opens first African office in South Africa
ICON acquires clinical research provider, BPA
ICON acquires UK-based regulatory consultancy, YRCR Ltd.
ICON acquires Central Laboratory in New York
ICON acquires bioanalytical consultancy, Pacific Research
ICON opens its first Middle East office in Israel
ICON begins trading on the Nasdaq exchange
ICON opens its first South American office in Buenos Aires, Argentina
ICON’s Hans Werner Voss conducts world’s first Adaptive Clinical Trial for an asthma study
ICON opens its first Asian office in Tokyo, Japan
ICON opens its first office in Germany
ICON opens its first US office in Philadelphia
ICON opens its first overseas office in Winchester, UK